Format

Send to

Choose Destination
J Clin Immunol. 2018 Feb;38(2):166-173. doi: 10.1007/s10875-018-0480-4. Epub 2018 Feb 6.

Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.

Author information

1
Pediatrics and Communicable Diseases, Pediatric Hematology/Oncology, University of Michigan, 1500 E. Medical Center Drive, D4202 Medical Professional Building, Ann Arbor, MI, 48109, USA. tmich@med.umich.edu.
2
Pediatrics - Genetics, University of Michigan, Ann Arbor, MI, USA.
3
Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
4
Department of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
5
Pediatric Hematology/Oncology, Oregon Health Sciences University, Portland, OR, USA.
6
Department of Internal Medicine, Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.
7
Pediatrics and Communicable Diseases, Pediatric Hematology/Oncology, University of Michigan, 1500 E. Medical Center Drive, D4202 Medical Professional Building, Ann Arbor, MI, 48109, USA.
PMID:
29411230
DOI:
10.1007/s10875-018-0480-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center